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Abstract
Background: Several high-throughput searches for ppotential natural antisense transcripts
(NATs) have been performed recently, but most of the reports were focused on cis type. A
thorough in silico analysis of human transcripts will help expand our knowledge of NATs.
Results: We have identified 568 NATs from human RefSeq RNA sequences. Among them, 403
NATs are reported for the first time, and at least 157 novel NATs are trans type. According to the
pairing region of a sense and antisense RNA pair, hNATs are divided into 6 classes, of which about
87% involve 5' or 3' UTR sequences, supporting the regulatory role of UTRs. Among a total of 535
NAT pairs related with splice variants, 77.4% (414/535) have their pairing regions affected or
completely eliminated by alternative splicing, suggesting significant relationship of alternative
splicing and antisense-directed regulation. The extensive occurrence of splice variants in hNATs
and other multiple pairing patterns results in a one-to-many relationship, allowing the formation of
complex regulation networks. Based on microarray data from Stanford Microarray Database, two
hNAT pairs were found to display significant inverse expression patterns before and after insulin
injection.
Conclusion: NATs might carry out more extensive and complex functions than previously
thought. Combined with endogenous micro RNAs, hNATs could be regarded as a special group of
transcripts contributing to the complex regulation networks.
Background
Natural antisense transcripts (NATs) are endogenous ones
that exhibit complementary sequences to transcripts of a
known function, or sense transcripts. NATs were first
described in prokaryotes [1], and they were found to
down-regulate the expression of sense transcripts involved
in diverse biological functions, such as transposition,
plasmid replication and gene expression [2]. Since the dis-
covery of first NAT in human [3], an increasing number of
NATs in mammalian organisms have been reported to be
related to genomic imprinting [4], RNA interference [5],
alternative splicing [6], X-inactivation [7] and RNA edit-
ing [8]. It has been shown that NATs could perform two
non-exclusive major functions: template for translation
and regulation of sense gene expression, and the latter
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port, stability and/or translation [9].
As NATs seemed to exist so extensively, independent
genome-wide searches for potential NATs were performed
recently with data from RefSeq, UniGene or some spe-
cially constructed EST database. Due to differences in data
sources and/or criteria used in searches, the number of
reported human NATs (hNATs) varies greatly, from hun-
dreds [10,11] to thousands [12,13].
There are two different types of NATs, cis and trans. A cis
NAT is transcribed from the opposite strand of the same
genomic locus as its sense RNA, thus the pair displays per-
fect sequence complementarity. In contrast, a trans NAT is
transcribed from a genomic locus different from its sense
counterpart and the pair may display imperfect comple-
mentarity [9]. All early works in human, mouse, and dro-
sophila revealed only cis NATs [14-16]. Although
increasing evidence suggests that trans NATs might per-
form more significant and versatile functions than previ-
ously expected [11], most of the high-throughput searches
were focused on cis NATs but overlooked trans ones
[10,12,13]. The bias towards cis type also existed in Kiyo-
sawa et al's survey on mouse genome [17]. Lehner et al.
[11] investigated both cis and trans NATs based on availa-
ble mRNAs, and found 372 human NATs including 80
putative trans ones. However, we believe that they under-
estimated the prevalence of hNATs since many known
antisense RNAs are non-protein coding.
In this work, we carried out a thorough in silico analysis of
human RNA sequences from the RefSeq database [18] and
identified 568 hNATs, among which 403 NATs were
reported for the first time. Out of the 313 novel NATs that
have genomic mapping data available, we determined
that 157 are trans NATs. We also classified the 568 NATs
according to pairing regions and found that 87% cases
involved UTR sequences of one or both transcripts. We
noticed that among a total of 535 NAT pairs related with
splice variants, 77.4% (414/535) have their pairing
regions affected or completely eliminated by alternative
splicing, suggesting significant relationship of alternative
splicing and antisense-directed regulation. We proposed
that the one-to-many relationship of sense and antisense
transcript pairs, caused by the extensive occurrence of
splice variants in hNATs and other multiple pairing pat-
terns, may lead to a probable regulatory network. Further-
more, using Stanford Microarray Database (SMD) [19],
we found two hNAT pairs displaying a significant inverse
expression pattern before and after insulin injection.
Results and Discussion
Identification of hNATs from RefSeq with BLASTN
Previous large-scale hNATs searches have significantly
expanded our knowledge about the prevalence of hNAT
[10-13]. Particularly, Chen et al. [13] predicted that about
20% of the human genes formed sense-antisense tran-
script pairs.
In this work, we studied hNATs with RefSeq [18], which is
a manually curated database that collects comprehensive,
non-redundant sets of sequences, and identified 568
hNATs including both cis and trans types (see Table 1 for
summary and Additional Table 1 for detailed information
of each pair). Although we found limited hNATs com-
pared to previous reports, sequence accession number
matching showed that 403 out of the 568 NAT pairs did
not appear in any of the published data sets [10-13], indi-
cating that antisense regulation may be even more wide-
spread in the mammalian genome than appreciated
previously.
The reason that previous studies did not find these entries
might be due to different starting data and/or the criteria
used. Most of these studies identified NATs based on
genomic locus overlapping. As a result, they tend to find
cis NATs, but overlooked trans ones [10,12,13]. For exam-
ple, Yelin et al. [12] mainly collected sequences that span
intron(s) from human expressed sequences (mRNAs and
expressed-sequence tags (ESTs)), and predicted 8.4% of
human transcription clusters formed cis NAT pairs. Simi-
larly, Chen et al. [13] investigated sense-orientation-relia-
ble ESTs from UniGene, and got the largest cis hNATs data
set reported to date. Non-polyadenylated transcripts were
not included in their study, which may partly explain why
they did not find the novel cis pairs in this work. We did
not exclude the possibility that some of the novel cis pairs
in this paper were actually included in Chen et al.'s results
[13] since our comparison was based on accession
number only and there are cases that a sequence entry
acquires a different primary accession number in follow-
ing releases due to sequence split or merge. Lehner et al.
[11] identified both trans and cis hNATs, but they only
considered mRNA, and ignored non-coding RNA which
occurs in many known functional NAT examples. Moreo-
ver, the newer version of RefSeq database that we used in
this work contains nearly twice as many entries of human
mRNA (25,827) as that in the previous version (12,897)
used by Lehner et al. [11]. As a result, we were able to iden-
tify more novel hNATs, particularly trans type NATs. The
568 hNATs are summarized in Table 1. Out of the 568
Table 1: Summary of hNAT pairs
Cis Trans Lacking genomic data Total
Novel 156 157 90 403
Reported 156 4 5 165
Total 312 161 95 568Page 2 of 8
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Genome database. Thus we determined that 312 NATs are
cis type and 161 are trans type (see Additional Table 1 for
detailed information). One hundred and fifty seven out of
the 161 trans NATs were reported for the first time. The
breadth and importance of trans NATs-directed gene regu-
lation are coming into focus as more trans encoded NATs,
particularly small nucleolar RNAs (snoRNAs) and micro
RNAs (miRNAs), are discovered [20-22]. To date, underly-
ing mechanisms of trans NATs are relatively less under-
stood than cis ones. The identification of more novel trans
NATs in this work may shed some light on this field.
It is noticeable that Lehner et al. concluded that 51 out of
their 80 trans hNATs were likely to be chimeric mRNA
containing sequences from two different chromosomal
loci due to artifacts of cDNA library construction and
chromosomal rearrangements [11]. However, after care-
fully checking the trans hNATs they reported, we found
that 21 out of the 23 RefSeq trans hNAT pairs thought to
be involving suspected chimeras can now be mapped to
certain loci, thus are true trans NATs. Among these 21
NATs, the chromosomal location information of 4 entries
was modified in the Genome database, suggesting that the
presence of trans NATs did affect the genome assembly
and gene localization as people worried about. It seems
that the temporal unfinished human genome assembly
was a major obstacle in their survey on trans hNATs.
Our data do not cover all of previously reported ones [10-
13]. This is due to our choice of using the RefSeq database
and the stringent criteria for BLASTN (e-value cutoff of 1e-
9 and identity above 98%). RefSeq includes both mRNAs
and non-mRNAs, but it has a bias towards mRNA because
of the convenience of identifying mRNA. There are 25827
human mRNA and 148 human non-mRNA entries in the
release of RefSeq we used. Thus, our choice of using Ref-
Seq helped to find coding antisense RNAs, while underes-
timated the non-coding antisense RNAs. For example, the
first reported hNAT over the c-myc locus, a non-coding
antisense transcript, cannot be found in our result [3].
Eighteen out of the 568 (3.2%) hNAT pairs we found
involved non-coding RNAs, which is significantly higher
than the expected 1.1%, assuming no bias for mRNA or
non-mRNA to form NAT pairs. The expected value is esti-
mated as 1–99.43%*99.43%, where 99.43% is the per-
centage of mRNA entries in the starting dataset. This
indicates that NATs tend to be non-coding RNAs, support-
ing Chen et al.'s observations [13], while disagreeing with
Lehner et al.'s assumption [11]. As new non-coding RNAs
are being discovered, we believe that the number of
reported NAT pairs will rise further.
Even though coding transcripts have fewer propensities to
form NAT pairs in contrast to non-coding ones, they have
been recently reported more frequently than before
[9,23,24]. Since coding NATs function as both template
and regulator, they may lead to more complex gene regu-
lation, as the THRA (c-erbAα) and NR1D1 (Rev-erbAα)
NAT pair example demonstrates below.
Classification of hNATs based on the pairing region
Assuming that the complementarity of sense and anti-
sense RNA pair is the major basis of the regulation func-
tion of antisense RNAs [9], we analyzed the overlapping
length and location of these 568 hNATs. It was found that
overlapping lengths varied from 34 bp to 1810 bp (see
Additional Table 1), similar to previously reported [10-
12]. We classified the 550 hNAT pairs that have CDS loca-
tion data into 6 types according to the pairing region: 1)
5'UTR vs. 5'UTR, 2) 5'UTR vs. CDS, 3) 5'UTR vs. 3'UTR, 4)
CDS vs. CDS, 5) CDS vs. 3'UTR, 6) 3'UTR vs. 3'UTR (Table
2). More than 87% of the 550 NAT pairs involved 5' or 3'
UTR, that is, types 1, 2, 3, 5 and 6, supporting the signifi-
cance of UTR in antisense-mediated regulation [9,25,26].
According to our data, the subtype 6-cis, or 3'UTR vs.
3'UTR-cis, is the most common form of overlapping.
While, analysis of adjacent gene sets in S. cerevisiae sug-
gested that there might be evolutionary pressure to select
against convergent genes [27], and the overlapping
arrangement of convergent genes restricted the elongation
of both transcripts, resulting in a severe reduction in
Table 2: Classification of hNAT pairs based on pairing region
Cis Trans Lacking genomic data Total
(1) 5'UTR vs. 5'UTR 20 7 5 32
(2) 5'UTR vs. CDS 37 16 13 66
(3) 5'UTR vs. 3'UTR 4 26 6 36
(4) CDS vs. CDS 48 1 22 71
(5) CDS vs. 3'TUR 85 19 23 127
(6) 3'UTR vs. 3'UTR 116 78 24 218
Lacking CDS 2 14 2 18
Total 312 161 95 568Page 3 of 8
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[28]. This collision effect could be a direct physical imped-
iment to the transcription machinery or an indirect effect
caused by supercoiling changes to the DNA template dur-
ing transcription, while seemed unrelated with interfer-
ence of antisense RNAs [28]. The precise biological
implication of the convergent arrangement of genes in
yeast and mammalian genomes remain to be elucidated.
The 6-cis dataset including 116 hNAT pairs might provide
basis for future in-depth investigation.
The subtype 1-cis, or 5'UTR vs. 5'UTR-cis NAT pairs, could
be involved in bidirectional transcription driven by a
divergent promoter, which seems to be a preferred struc-
ture in prokaryotes for gene regulation such as transcrip-
tion coupling [29]. Transcription coupling is different
from the traditional concept of antisense phenomena,
and the choice between transcription coupling and anti-
sense transcript-directed inhibition may depend on the
overlapping length and involved transcription factor
binding sites. Since bi-directional transcription in eukary-
otes is not as common as in prokaryotes, the precise
organization and its significance of the 20 members of
type 1-cis are intriguing. An in-depth analysis is still in
progress.
Splice variants involved in hNATs
Since the wide existence of alternative splicing has been
well established [30], and there is evidence for the
involvement of NATs in alternative splicing [31,32], we
also investigated the splice variants involved in hNATs. In
the present 568 NATs pairs, 63 genes involved in 168 NAT
pairs have splice variants (see Additional Table 2A). Forty-
nine of the 63 genes involved in 121 pairs have pairing
regions unaffected by alternative splicing; while the other
14 genes involved in 47 pairs have variable pairing
regions due to alternative splicing. As an example for the
latter case, the SPAG8 gene has two splice variants,
NM_012436 and NM_172312, and they may pair with
antisense transcript NPR2 with 308 bp overlap of 99%
identity, and 110 bp overlap of 100% identity, respec-
tively. It is conceivable that alternative splicing can also
make the whole pairing region lost. In case of the IL18BP
gene (see Additional Table 2A), it has four splice variants,
but only three of them have antisense transcript NUMA1.
To see how frequently this can happen, we checked the
rest 400 hNAT pairs (568-168) using AceView [33] and
found that additional 367 NAT pairs involved splicing
variants (see Additional Table 2B). In these cases, only
one of the transcript variants pairs with its countertran-
script while the others lose the pairing region because of
alternative splicing. Therefore these cases were not con-
tained in Additional Table 2A. Among the 535 NAT pairs
(168+367) related with splice variants, 22.6% (121/535)
have splicing variants sharing the same pairing region,
77.4% (414/535) have their pairing regions affected or
completely eliminated by alternative splicing. The
remarkably high percentage of the latter suggested signifi-
cant relationship of alternative splicing and antisense-
directed regulation. Taking the THRA (c-erbAα) and
NR1D1 (Rev-erbAα) pair (No. 472 in the Additional
Table 1) as an example, the sense transcript c-erbAα
encodes two structurally related proteins R-erbAα1 and R-
erbAα2 by alternative splicing [23]. The antisense rev-
erbAα transcript is complementary to the last exon of r-
erbAα2 mRNA but not to the r-erbAα1 mRNA. It was indi-
cated that rev-erbAα messenger prevents sense r-erbAα
primary transcript splicing into r-erbAα2 mRNA by RNA
masking, thus tilting the balance towards R-erbAα1 syn-
thesis and ultimately modulating cellular response to hor-
mone [6,22,23,31,34]. The inhibition of splicing by NAT
complementary to sequences remote from the splice site is
specific and efficient, which might be attributed to block-
ing of regulatory elements within the exon essential for
exon selection and intron removal, disruption of pre-
mRNA secondary structure important for splicing, or dis-
ruption of RNP structure required for assembly of a func-
tional RNA-splicing complex [22,35]. As a result, NAT
dictates the way how a sense transcript is differentially
spliced. A further analysis of the 414 NATs pairs involving
splicing variants with different overlaps may help uncover
underlying mechanisms.
Also in the above example, the antisense transcript
encodes protein Rev-erbAα (NR1D1) which happens to
belong to the thyroid/steroid hormone receptor family,
same as products of sense transcripts [9]. This example
illustrates the dual roles of some NATs: template for trans-
lation and regulator of sense gene expression. Such a gene
structure is quite exquisite and economic to organize
functionally related genes.
One-to-many relationship in hNATs
Initially, NAT pairs were considered to have one-to-one
relationship. However, an antisense transcript might form
duplex with more than one splice variants of a sense gene,
as the examples given in previous section. In theory, an
antisense transcript has also the potential to pair with
more than one paralogous sense transcripts. Finally, more
than one antisense transcripts may pair with one sense
transcript at different parts of its sequence. In the 568
hNAT pairs, besides the 168 entries that form one-to-
many relationship caused by alternative splicing, addi-
tional 97 hNAT pairs were found to have one-to-many
relationship due to different pairing regions. That makes
47% ((97+168)/568) of the total, allowing NATs to form
complex regulation networks. Figure 1 is an example of
such a network including 29 genes involved in 40 hNATs.
Interestingly, all hNAT pairs with genomic mapping data
are trans type. In fact, hNAT pairs in this paper formed 38Page 4 of 8
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is worth noting that these networks mainly involve trans
NATs, same as the example in Figure 1. The trans relation-
ship seems more flexible, thus provides greater chance for
transcripts to "communicate" with each other. In addition
to RNA masking mentioned above, there is now strong
evidence that the interaction of antisense partners can also
affect gene expression via the activation of dsRNA-
dependent pathways [22,36]. These might include RNA
interference (RNAi)-dependent gene silencing. It was
reported that several different micro RNAs could regulate
the expression of the same target mRNA based on comple-
mentarity between micro RNA and mRNA [21]. It seems
that the one-to-many relationship, notably in transcrip-
tional regulation, might be common as the list of known
one-to-many regulatory interactions becomes more com-
prehensive. From this perspective, the biological signifi-
cance of trans NATs deserves to be further investigated
systematically.
Identification of two hNAT pairs with inverse expression 
pattern
There have been reports that sense and antisense tran-
scripts show inverse expression pattern, as well as exam-
ples of coordinated regulation of both transcripts
[9,10,12,37]. It is more intriguing that sense and antisense
transcripts are differentially expressed depending on tis-
sue types or development stages [25,38,39]. All these phe-
nomena illustrated that the underlying mechanism is
complicated and confusing. In this work we focused on
identifying inverse expression pattern under certain con-
dition for the hNAT pairs we found, considering that this
pattern is the most common one for sense-antisense
expression.
Microarray is a high-throughput technology for analyzing
gene expression and has been recently applied to study
NATs [12]. In this work, we used data from SMD [19] for
in silico expression analysis of the hNATs we found. Rome
et al. [40]designed a microarray of 29308 cDNA probes to
evaluate gene expression pattern of skeletal muscle cells
from six independent volunteers before and after insulin
injection. We found that 150 out of the 568 NATs
reported in this work had representing probes in the array,
so we selected the expression data of 121 NATs with no
less than 3 repeat samples for analysis. T-test and multi-
plicity adjustment showed that relative quantity (RQ) val-
ues of two NAT pairs, SARM1/MGC9564 (No. 550 in
Additional Tables 1 and 4) and HARS/WDR55 (No. 443
in Additional Tables 1 and 4), varied significantly after
insulin injection, showing the two pairs displayed inverse
expression pattern. The calculation result is presented in
Additional Table 4.
For the SARM1/MGC9564 pair, RQ value rose after insu-
lin injection, indicating SARM1 is relatively up-regulated
in contrast to MGC9564. SARM1 mRNA encodes a con-
served protein with a SAM motif and is highly expressed
in liver and kidney [41]. It was reported that a 0.4 kb anti-
sense transcript was coordinately expressed with the
SARM1 gene, but this is apparently not the same NAT as
we found [41], suggesting that the SARM1 gene has at
least two antisense partners. MGC9564 is an experimen-
tally supported full-length mRNA (2096 bp) with a pre-
Human NAT interaction network constituted by one-to-many relationshipFigure 1
Human NAT interaction network constituted by one-to-many relationship. Gene symbol represents a gene. Bold-
face gene symbols represent genes with variants which could pair with a same countertranscript. A dashed line indicates an 
uncertain type due to lacking genomic mapping data; a solid line with bi-directional arrows indicates a trans type. There is no 
cis-NAT shown in this figure.Page 5 of 8
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SARM1 mRNA and MGC9564 mRNA possibly form a
CDS vs. 3'UTR cis NAT pair.
For the second pair, HARS/WDR55, the relative quantity
decreased after insulin injection, indicating HARS is
down-regulated relative to WDR55. HARS mRNA codes
for histidyl-tRNA synthetase, which is essential for the
incorporation of histidine into proteins [42]. The WDR55
cDNA was cloned recently [43], and has not yet been sub-
jected to final review in the latest release of NCBI RefSeq
database. Based on the chromosomal location informa-
tion, the two genes are mapped closely (5q31.3), but do
not overlap. They may form a 3' UTR vs. 3' UTR trans NAT
pair. This is a novel pair that we reported for the first time.
The apparent inverse expression pattern of the above two
hNAT pairs suggests their possible regulatory roles in skel-
etal muscle cells after insulin injection. Further experi-
mental studies are needed to unravel the underlying
mechanism.
Conclusion
Through a systematic analysis of hNATs using RefSeq
dataset, we identified 568 hNATs. Even though the total
number is less than those reported by Yelin et al. [12] and
Chen et al. [13], many novel hNATs, particularly trans
NATs, were discovered in this work. Among the NAT pairs
involving splice variants, a remarkably high percentage
(77.4%) have their pairing regions affected or completely
eliminated by alternative splicing, suggesting significant
relationship of alternative splicing and antisense-directed
regulation. The extensive occurrence of splice variants in
hNATs and other multiple pairing patterns results in one-
to-many relationship, allowing the formation of complex
regulation networks. It seemed that trans NATs bring more
flexibility and complexity to antisense-directed gene regu-
lation. Furthermore, out of the 121 hNATs with expres-
sion data available, we found that the expression pattern
of two NAT pairs in the skeletal muscle cells showed sig-
nificant inverse relationship before and after insulin injec-
tion.
In summary, NATs might carry out more extensive and
complex functions than previously thought. Combined
with endogenous micro RNAs, hNATs could be regarded




Human transcript sequences (25,827 in total) were
extracted from RefSeq release 2 [18]. Genomic mapping
data were taken from the Genome database version 35.1
at NCBI [44]. Alternative splicing information was
obtained from AceView [33]. Microarray data used for in
silico expression analysis were downloaded from Stanford
Microarray Database (SMD) [19].
Search for hNATs
The BLASTN program was used to identify putative hNATs
with an e-value cutoff of 1e-9 and identity threshold of
98%. Query sequences were all human RNA sequences
extracted from the RefSeq database, and the subject data-
base was made up with reverse complement sequences of
all query sequences. Option -S was set to be 1 to avoid the
program reverse-complementing query sequences auto-
matically. After getting BLASTN hits, we compared pairing
sequence segments to the repetitive sequence database,
RepBase [45], and confirmed that they contained no
known repetitive sequence. We also used ClustalW to
align all pairing segments to make sure there was no novel
repeats. These two steps are necessary to eliminate the
possibility of repetitive element-induced prevalence of
hNATs.
Classification of hNATs according to genomic location and 
pairing region
Human NATs were divided into cis and trans types accord-
ing to relative genome location using genomic mapping
data from the Genome database [44]. That is, the NAT
transcribed from the opposite strand of the same genomic
locus as its sense RNA is cis, while the NAT transcribed
from a genomic locus different from its sense counterpart
is trans. Based on the pairing region of sense and antisense
transcripts, we also defined 6 types: 1) 5'UTR vs. 5'UTR, 2)
5'UTR vs. CDS, 3) 5'UTR vs. 3'UTR, 4) CDS vs. CDS, 5)
CDS vs. 3'UTR, and 6) 3'UTR vs. 3'UTR, where the "CDS"
contains "CDS", "CDS+3'UTR", "CDS+5' UTR" and
"5'UTR+CDS+3' UTR".
Expression analysis of hNATs using SMD data
Gene expression data of human skeletal muscle cells
before and after insulin injection are available in SMD
[19,40]. Since human cDNA probes in these data are iden-
tified with UniGene cluster IDs, antisense transcripts can
be mapped to corresponding probes based on the rela-
tionship between UniGene cluster ID and RefSeq acces-
sion number (ACC), by which expression data of hNATs
were retrieved. Human NATs with data from 3 or more
repeat samples were selected for statistical analysis. The
ratio of sense to antisense transcript expression levels rep-
resents the relative quantity (RQ) of a NAT pair, RQ = S/
A. The change of the ratio of a pair after insulin injection
is expressed as the ratio of two relative quantities, R = RQa/
RQb, where RQb and RQa are relative quantities before and
after insulin injection, respectively. This R value is used to
check if a NAT pair shows an inverse expression pattern
under the given condition. T-test with a significance level
of 0.05 and Bonferroni's adjustment for multiplicity werePage 6 of 8
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change of a NAT pair in expression pattern.
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